Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11930073 | 0.85 | PIK3CD (0.32) | PIK3CD | |
| SCHEMBL24966589 | 0.82 | PIK3CD (0.31) | PIK3CD | |
| SCHEMBL178547 | 0.72 | — | — | |
| SCHEMBL2921685 | 0.69 | — | — | |
| SCHEMBL104118 | 0.69 | PIK3CD (0.32) | PIK3CD | |
| SCHEMBL28382008 | 0.69 | — | — | |
| SCHEMBL3184787 | 0.69 | — | — | |
| SCHEMBL458834 | 0.69 | — | — | |
| SCHEMBL22388730 | 0.69 | — | — | |
| SCHEMBL3489137 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9226925-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2016-01-05 | — | — | US | claimed |
| US-8940729-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2015-01-27 | — | — | US | claimed |
| US-8912217-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2014-12-16 | — | — | US | claimed |
| CN-119677819-A | Azo compound or salt thereof, and polarizing film, polarizing plate and liquid crystal display device each containing the same | 日本化药株式会社 | 2025-03-21 | — | — | CN | disclosed |
| US-20240262850-A1 | PHOSPHITE COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-08-08 | — | — | US | disclosed |
| US-20240166672-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-05-23 | — | — | US | disclosed |
| EP-4349920-A1 | PHOSPHITE ESTER COMPOSITION | Sumitomo Chemical Company Limited (JP) | 2024-04-10 | — | — | EP | disclosed |
| EP-4317166-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME, AND USE APPLICATION FOR SAME | Sumitomo Chemical Company Limited (JP) | 2024-02-07 | — | — | EP | disclosed |
| CN-117413025-A | Phosphite compositions | 住友化学株式会社 | 2024-01-16 | — | — | CN | disclosed |
| CN-114026199-B | Polarized light emitting film, polarized light emitting panel and display device containing water-soluble coumarin compound or salt thereof | 日本化药株式会社 | 2023-12-26 | — | — | CN | disclosed |
| CN-117120454-A | Phosphite compound, process for producing the same, and use thereof | 住友化学株式会社 | 2023-11-24 | — | — | CN | disclosed |
| US-5874494-A | DETERIORATION STABILIZER FOR THERMOPLASTIC RESIN; OXIDATION RESISTANCE, DISCOLORATION INHIBITION, HEAT RESISTANCE, CROSSLINKING INHIBITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-02-23 | — | — | US | disclosed |
| US-5847187-A | Organic phosphorous compound, a process for producing the same and a use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-12-08 | — | — | US | disclosed |
| US-5843339-A | Phosphites and their production and use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-12-01 | — | — | US | disclosed |
| US-5830936-A | THERMAL STABILIZERS FOR POLYOLEFINS AND ENGINEERING PLASTICS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-11-03 | — | — | US | disclosed |
| EP-0861847-A2 | Stabilizer composition and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-09-02 | — | — | EP | disclosed |
| EP-0823435-A2 | Phosphites, process for producing the same and their use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-02-11 | — | — | EP | disclosed |
| EP-0767175-A1 | Phosphites and their production and use | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1997-04-09 | — | — | EP | disclosed |
| US-5576365-A | HEAT AND OXIDATION RESISTANCE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-11-19 | — | — | US | disclosed |
| EP-0684279-A1 | A phosphorus type stabilizer and an organic material stabilized by the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-11-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166672-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME | EBPL, ACSL6, ACSL3 | PIK3CD 551/4885GAA 2834/4885HTT 4263/4885 |
| US-20240262850-A1 | PHOSPHITE COMPOSITION | PHOSPHO1, PLCG2, PPA1 | PIK3CD 169/4885GAA 3424/4885HTT 2573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.